Unknown

Dataset Information

0

Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.

ABSTRACT:

SUBMITTER: Abdel-Rahman O 

PROVIDER: S-EPMC6494548 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy.
| S-EPMC8268608 | biostudies-literature
Unknown Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.
| S-EPMC4298376 | biostudies-literature
Unknown Gemcitabine with carboplatin for advanced biliary tract cancers: a phase II single institution study.
| S-EPMC3028583 | biostudies-literature
Unknown Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report.
| S-EPMC5228213 | biostudies-literature
Unknown Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.
| S-EPMC3000850 | biostudies-other
Unknown Current status of chemotherapy for the treatment of advanced biliary tract cancer.
| S-EPMC3759755 | biostudies-literature
Unknown Preoperative biliary drainage for biliary tract and ampullary carcinomas.
| S-EPMC2794354 | biostudies-other
Unknown Gemcitabine and capecitabine for advanced biliary cancer.
| S-EPMC5582046 | biostudies-literature
Unknown Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.
| S-EPMC4007244 | biostudies-literature
Unknown Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
| S-EPMC4648082 | biostudies-literature